Cell biologist Andrew Ewald is known for his discoveries in how breast cancer cells spread through the body at the cellular level. With a year as department director under his belt, we spoke with Ewald about his first year and the future of cancer metastasis research.
Latest research findings from the Institute for Basic Biomedical Sciences
Fundamentals
Pancreatic cancer is the deadliest major cancer type, but Johns Hopkins Medicine biomedical engineers discovered a way to predict how likely a patient with pancreatic cancer will respond to treatment and survive.
Researchers are designing a system to ethically collect and generate a data set with various types of information that will be useful for many generations of scientists who specialize in using machine learning to solve challenging issues in human health.
For many people with diabetes, implanted crystalline drug-loaded hydrogels help produce much needed insulin, but their immune systems attack the implants, making them less functional. Biomedical engineer Joshua Doloff and his Technion partner Shady Farah received a $700,000 grant from JDRF to address this issue.
20 scholars will pursue doctorate degrees at The Johns Hopkins University as part of a new $150 million initiative to address historic underrepresentation in science, technology, engineering and math fields.
Every time a cell divides, our chromosomes duplicate, providing each daughter cell with an accurate copy of our DNA. If our cells had no way to capture each complete copy, that would be chaotic. Fortunately, they have tiny machines that help put each copy in the right place.
Johns Hopkins scientists have found a way to make glucose meters detect COVID-19 antibodies. Now, they’re trying to get it in the hands of the consumer.
Thanks to many generous donors, the Johns Hopkins School of Medicine Brain Resource Center has a large tissue repository for Johns Hopkins University faculty and academics across the country.
What do an amoeba, worms and fruit flies have in common? They’re each used by researchers at Johns Hopkins Medicine to research human muscle, cell machinery, and cell development.
Last year, the World Health Organization reclassified brain tumors with a strong emphasis on differences at the molecular level. JHM neurosurgeon Alan Cohen, M.D., published an article about how these approaches can offer targeted therapy to improve outcomes and reduce treatment complications.
The Johns Hopkins team contributed key research to the effort, which will provide a clearer picture of how DNA affects the risks of diseases and how genes are expressed and regulated.
Sign Up for Fundamentals
Stay up-to-date with the latest research findings from the Institute for Basic Biomedical Sciences.
Please enter a valid email address.
Questions, Comments or Story Suggestions?
Please contact Vanessa Wasta and Ayanna Tucker, Fundamentals Editors, at wasta@jhmi.edu and atucke25@jhmi.edu.